Mandatory Labelling or Import Ban?: Two-Country Trade with Biotechnology Products
This paper examines trade and welfare effects of biotechnology. While biotechnology lowers production costs, it also lowers perceived quality of products. Without labelling, consumers cannot distinguish between biotechnology and conventional products. In a simple general equilibrium model of two-country trade, it is shown that when a biotechnology product is invented in one country, the importing country may lose from trade under free trade without labelling. The importing country can be better off by requiring labelling for the biotechnology product. If labelling cost is high, however, the importing country may prefer to ban the import of the biotechnology product.
|Date of creation:||Apr 2003|
|Date of revision:|
|Note:||This version: February 12, 2003|
|Contact details of provider:|| Phone: +81-42-580-8000|
Web page: http://www.econ.hit-u.ac.jp/
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:hit:econdp:2003-03. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Digital Resources Section, Hitotsubashi University Library)
If references are entirely missing, you can add them using this form.